C3441021 | TALAPRO-2
NCT03395197
JCP061
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC (TALAPRO-2)
Status:
Recruiting
III
Phase
1st
Line of Therapy
Advanced / Metastatic
Disease Stage
Biomarker(s)
DDR
Investigational
Product
Talazoparib
PARP inhibitor (p.o.)
Treatment Arms
o Experimental: Combination arm
o Active Comparator: Monotherapy arm